Effects of IGF-I combined with GH on glucocorticoid-induced changes of bone and connective tissue turnover in man

Journal of Endocrinology

Volumn 162, Issue 2, 1999, Pages 259-264

  Berneis, K ^a   Oehri, M ^a   Kraenzlin, M ^a   Keller, U ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYPYRIDINOLINE; GLUCOCORTICOID; GROWTH HORMONE; HYDROXYPROLINE; MEPREDNISONE; OSTEOCALCIN; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; PYRIDINOLINE; SOMATOMEDIN C;

ARTICLE; BONE TURNOVER; CELL ACTIVITY; CLINICAL TRIAL; COLLAGEN SYNTHESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OSTEOLYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; URINARY EXCRETION;

EID: 0032775883     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1620259     Document Type: Article

References (37)

1. Amato G, Carella C, Fazio SA, Cittadini MGL, Sabatini D, Marciano MC, Sacca L & Bellastella A 1993 Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. Journal of Clinical Endocrinology and Metabolism 77 1671-1676.
2. Aslam F, Shalhoub V, van Wijnen A, Banerjee C, Bortell R, Shakoori A, Litwack G, Stein JL, Stein GS & LianJB 1995 Contribution of distal and proximal promoter elements to glucocorticoid regulation of osteocalcin gene transcription. Molecular Endocrinology 9 679-690.
3. Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A & Johnston DG 1994 The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clinical Endocrinology 40 383-391.
4. Black D, Duncan A & Robins S 1989 Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Analytical Biochemistry 169 197-203.
5. Centrella M, Spinelli HM, Persing JA & McCarthy TL 1993 Invited discussion: The complexity of insulin-like growth factors in bone growth and remodeling. Annals of Plastic Surgery 31 434-438.
6. Chevalley T, Strong D, Mohan S, Baylink D & Linkhart T 1996 Evidence for a role for insulin-like growth factor binding proteins in glucocorticoid inhibition of normal human osteoblast-like cell proliferation. European Journal of Endocrinology 134 591-601.
7. Conover CA, Clarkson JT & Bale LK 1993a Phorbol ester tumor promoters regulate insulin-like growth factor-binding protein-4 proteolysis. Endocrinology 133 1347-1351.
8. Conover CA, Kiefer MC & Zapf J 1993b Post-translational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. Journal of Clinical Investigation 91 1129-1137.
9. Crofton PM 1982 Biochemistry of the alkaline phosphatase isoenzymes. Critical Review of Clinical Laboratory Sciences 16 161-194.
10. Delany A, Dong Y & Canalis E 1994 Mechanisms of glucocorticoid action in bone cells. Journal of Cellular Biochemistry 56 295-302.
11. Durham SK, Kiefer MC, Riggs BL & Conover CA 1994 Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology. Journal of Bone and Mineral Research 9 111-117.
12. Ebeling PR, Jones JD, Fallen WMO, Janes CH & Riggs BL 1993 Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. Journal of Clinical Endocrinology and Metabolism 77 1384-1387.
13. Hahn T, Halstead L & Teitelbaum S 1979 Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. Journal of Clinical Investigation 64 655-665.
14. Holloway L, Butterfield G, Hintz RL, Gesundheit N & Marcus R 1994 Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. Journal of Clinical Endocrinology and Metabolism 79 470-479.
15. Johansson AG, Lindh E & Ljunghall S 1992 Insulin-like growth factor I stimulates bone turnover in osteoporosis. Lancet 339 1619.
16. Johansson AG, Lindh E & Ljunghall S 1993 Growth hormone, insulin-like growth factor I, and bone: a clinical review. Journal of Internal Medicine 234 553-560.
17. Johansson AG, Lindh E, Blum WF, Kollerup G, Sorensen OH & Ljunghall S 1996 Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. Journal of Clinical Endocrinology and Metabolism 81 44-48.
18. Jux C, Leiber K, Hugel U, Blum W, Ohlsson C, Klaus G & Mehls O 1998 Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH-and IGF-I-receptor in cultured rat chondrocytes. Endocrinology 139 3296-3305.
19. Kamyar A, Pirola CJ, Wang HM, Sharifi B, Mohan S, Forrester JS & Fagin JA 1994 Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cells. Circulation Research 74 576-585.
20. Langdahl BL, Kassem M, Moller MK & Eriksen EF 1998 The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone. European Journal of Clinical Investigation 28 176-183.
21. Libanati CR & Baylink DJ 1992 Prevention and treatment of glucocorticoid-induced osteoporosis. A pathogenetic perspective. Chest 102 1426-1435.
22. Lukert BP & Raisz LG 1990 Glucocorticoid-induced osteoporosis: pathogenesis and management [see comments]. Annals of Internal Medicine 112 352-364.
23. Mauras N, Doi S & Shapiro J 1996 Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans. Journal of Clinical Endocrinology and Metabolism 81 2222-2226.
24. McCarthy TL, Centrella M & Canalis E 1990 Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells. Endocrinology 126 1569-1575.
25. McCarthy TL, Casinghino S, Centrella M & Canalis E 1994 Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors. Journal of Cellular Physiology 160 163-175.
26. Meyer T, Gustafsson J & Carlstedt-Duke J 1997 Gluco-corticoid-dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box. DNA and Cell Biology 16 919-927.
27. Oehri M, Ninnis R, Girard J, Frey FJ & Keller U 1996 Effects of growth hormone and of IGF-I on glucocorticoid induced protein catabolism in humans. American Journal of Physiology 270 E552-E558.
28. Oikarinen A, Autio P & Vuori J 1992 Systemic glucocorticoid treatment decreases serum concentration of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen. British Journal of Dermatology 126 172-178.
29. Ortoft G, Bruel A, Andreassen T & Oxlund H 1995 Growth hormone is not able to counteract osteopenia of rat cortical bone induced by glucocorticoid with protracted effect. Bone 17 543-548.
30. Podenphant J, Larsen NE & Christiansen C 1984 An easy and reliable method for determination of urinary hydroxyproline. Clinica Chimica Acta 142 145-148.
31. Reid IR 1989 Pathogenesis and treatment of steroid osteoporosis. Clinical Endocrinology 30 83-103.
32. Riggs B, Tsai K & Mann K 1986 Effect of acute increases in bone matrix degradation on circulating levels of bone Gla-protein. Journal of Bone and Mineral Research 1 539-542.
33. Seibel M, Dimcam A & Robins S 1989 Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic disease. Journal of Rheumatology 16 964-970.
34. Suzuki Y, Ichikawa Y, Saito E & Homma M 1983 Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 32 151-156.
35. Swolin D, Brantsing C, Matejka G & Ohlson C 1996 Cortisol decreases IGF-I mRNA levels in human osteoblasts-like cells. Journal of Endocrinology 149 397-403.
36. Unterman TG & Phillips LS 1985 Glucocorticoid effects on somatomedins and somatomedin inhibitors. Journal of Clinical Endocrinology and Metabolism 61 618-626.
37. Woessner JF 1961 The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Archives of Biochemistry and Biophysics 93 440-447.